FABP2 and Parkinson disease: Furthermore, intestinal fatty acid-binding protein (FABP2) co-localizes with α-syn, and its plasma levels correlate with disease progression in PD, suggesting its involvement in α-syn uptake and aggregation as a potential disease biomarker.147